Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
Hiroyuki Takai(Hiroshima City University), Noboru Motoyama(National Center for Geriatrics and Gerontology), Makoto Nakanishi(The Cancer Institute Hospital), Naoki Harada(Osaka Prefecture University), Ettore Appella(National Institutes of Health), Hirofumi Sawa(Sapporo International University), Yuki Okada(Quantitative BioSciences), Kyoji Ikeda(National Center for Geriatrics and Gerontology), Shinichi Saito(Pharmaceutical Biotechnology (Czechia)), Miho Watanabe, Hiroshi Suzuki(University of Tokyo Hospital), Kazuo Nagashima(Sapporo Medical University), Carl W. Anderson(Signum Computer (Germany)), Kazuhito Naka(Kanazawa University)
Cited by 436
Related Papers
DNA damage activates p53 through a phosphorylation–acetylation cascade
|Genes & Development|1998|1.2k
Post‐translational modifications and activation of p53 by genotoxic stresses
|European Journal of Biochemistry|2001|1.1k
Navigating the DNA methylation landscape of cancer
|Trends in Genetics|2021|1k
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.
|Proceedings of the National Academy of Sciences|1979|732